| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.045 | 0.5 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.043 | 0.5 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.043 | 0.5 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |